Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 23:16:1555407.
doi: 10.3389/fneur.2025.1555407. eCollection 2025.

Gender disparities in cognitive impairment across neurological autoimmune disorders: a systematic review

Rahma Ouled Toumi  1 , Chalachew Kassaw  1   2 , Valeriia Demareva  1
Affiliations

Gender disparities in cognitive impairment across neurological autoimmune disorders: a systematic review

Rahma Ouled Toumi et al. Front Neurol. .

Abstract

Introduction: Neurological autoimmune disorders (NADs) often intertwine with cognitive impairment (CI), representing a multi-layered challenge in both clinical understanding and therapeutic management. The compounded burden of NADs and CI not only significantly affects patient's quality of Life (QoL), condition's prognosis, and treatment outcomes, but disproportionately impacts women, who are inherently more susceptible to autoimmunity. This review endeavors to investigate gender-based cognitive deficits, their underlying mechanisms, and their clinical implications. We will focus on Hashimoto's thyroiditis (HT), Graves' disease (GD), fibromyalgia (FMS), Guillain-Barré syndrome (GBS), myasthenia gravis (MG), multiple sclerosis (MS), and narcolepsy type 1 (NT1).

Methods: A systematic search of PubMed and the Cochrane Library was conducted for peer-reviewed articles published in the last decade. The search included the keywords "cognitive impairment," "cognitive decline," "gender disparities," "neurological autoimmune disorders," "Hashimoto's thyroiditis," "graves' disease," "multiple sclerosis," "fibromyalgia," "Guillain-Barre syndrome," "myasthenia gravis," and "narcolepsy type 1″. A manual search also took place to uncover grey literature and additional studies we already know exist that did not appear in the two main databases. After applying inclusion and exclusion criteria, 14 articles were selected for analysis. These articles were evaluated for their contribution to unraveling gender-based cognitive impairment trends across NADs and the possible factors involved.

Results: The systematic search yielded a limited number of relevant studies addressing gender disparities in CI across NADs and, apart from MS, most conditions remain under-researched, indicating a significant research gap. While evidence suggests gender-based differences in the manifestations and severity of CI, these findings highlight the necessity for further investigations and innovative clinical approaches tailored to these distinctions.

Conclusion: CI remains a critical, underexplored aspect of NADs, with gender disparities receiving even less attention. Our review highlights a research imbalance and a lack of specific investigations, leading to overgeneralized conclusions about CI across NADs and a limited understanding of the various involved mechanisms. Clinically, addressing CI in NADs requires comprehensive cognitive assessments that account for gender differences, alongside equitable access to resources and personalized treatment approaches. Future advancements are likely to revolve around diagnostic innovations, precision medicine, interdisciplinary collaborations, and holistic approaches to chronic disease management.

Keywords: cognition; cognitive gender disparities; cognitive impairment; neuroimmunology; neurological autoimmune disorders; systematic review; women’s health.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Prisma guideline gender disparities in Cl in NADs.
Figure 2
Figure 2
Current landscape of HT-related Cl.
Figure 3
Figure 3
Potential mechanisms of levothyroxine-induced CI in AITD.
See this image and copyright information in PMC

References

    1. Calissendorff J, Cramon PK, Hallengren B, Khamisi S, Lantz M, Planck T, et al. . Long-term outcome of Graves' disease: a gender perspective. Women's Health Rep. (2023) 4:487–96. doi: 10.1089/whr.2023.0073, PMID: - DOI - PMC - PubMed
    1. Jiang L, D'Souza RS, Oh T, Vincent A, Mohabbat AB, Ashmore Z, et al. . Sex-related differences in symptoms and psychosocial outcomes in patients with fibromyalgia: a prospective questionnaire study. Mayo Clin Proc Innov Qual Outcomes. (2020) 4:767–74. doi: 10.1016/j.mayocpiqo.2020.06.009, PMID: - DOI - PMC - PubMed
    1. Segura-Jiménez V, Estévez-López F, Soriano-Maldonado A, Álvarez-Gallardo IC, Delgado-Fernández M, Ruiz JR, et al. . Gender differences in symptoms, health-related quality of life, sleep quality, mental health, cognitive performance, pain-cognition, and positive health in Spanish fibromyalgia individuals: the Al-Ándalus project. Pain Res Manag. (2016) 2016:5135176–14. doi: 10.1155/2016/5135176, PMID: - DOI - PMC - PubMed
    1. Iannuccelli C, Lucchino B, Gioia C, Dolcini G, Rabasco J, Venditto T, et al. . Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia. Clin Rheumatol. (2022) 41:2171–8. doi: 10.1007/s10067-022-06133-y, PMID: - DOI - PMC - PubMed
    1. Khan F, Pallant JF, Ng L, Bhasker A. Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome. J Neurol. (2010) 257:2024–31. doi: 10.1007/s00415-010-5653-x, PMID: - DOI - PubMed

Publication types

LinkOut - more resources